Theradiag, an in vitro diagnostics and theranostics company based in France, will use $1.6 million from Oséo to design test kits as part of its collaborative effort with Splicos and the French National Center for Research and Science. The project, called CaReNA, is aimed at developing diagnostic tests and RNA-targeting therapeutics for obesity and HIV/AIDS.
French firm wins funds for work on HIV/AIDS, obesity
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||